These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15996915)

  • 1. MLL-PTD as a marker for minimal residual disease studies: quantification counts.
    Thiede C
    Haematologica; 2005 Jul; 90(7):865B. PubMed ID: 15996915
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk assessment by monitoring expression levels of partial tandem duplications in the MLL gene in acute myeloid leukemia during therapy.
    Weisser M; Kern W; Schoch C; Hiddemann W; Haferlach T; Schnittger S
    Haematologica; 2005 Jul; 90(7):881-9. PubMed ID: 15996925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency of additional gene mutations in acute myeloid leukemia with MLL partial tandem duplication: DNMT3A mutation is associated with poor prognosis.
    Kao HW; Liang DC; Kuo MC; Wu JH; Dunn P; Wang PN; Lin TL; Shih YS; Liang ST; Lin TH; Lai CY; Lin CH; Shih LY
    Oncotarget; 2015 Oct; 6(32):33217-25. PubMed ID: 26375248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FLT3-ITD and MLL-PTD influence the expression of MDR-1, MRP-1, and BCRP mRNA but not LRP mRNA assessed with RQ-PCR method in adult acute myeloid leukemia.
    Nasilowska-Adamska B; Solarska I; Paluszewska M; Malinowska I; Jedrzejczak WW; Warzocha K
    Ann Hematol; 2014 Apr; 93(4):577-93. PubMed ID: 24030729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapse kinetics in acute myeloid leukaemias with MLL translocations or partial tandem duplications within the MLL gene.
    Ommen HB; Hokland P; Haferlach T; Abildgaard L; Alpermann T; Haferlach C; Kern W; Schnittger S
    Br J Haematol; 2014 Jun; 165(5):618-28. PubMed ID: 24611505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Mixed Lineage Leukemia Gene (MLL)/MLLT10 Fusion Transcripts by Reverse Transcription-PCR and Sequencing in a Case of AML With a FISH-Negative Cryptic MLL Rearrangement.
    Ko K; Kwon MJ; Woo HY; Park H; Park CH; Lee ST; Kim SH
    Ann Lab Med; 2015 Jul; 35(4):469-71. PubMed ID: 26131423
    [No Abstract]   [Full Text] [Related]  

  • 7. A partial nontandem duplication of the MLL gene in four patients with acute myeloid leukemia.
    Sárová I; Brezinová J; Zemanová Z; Lizcová L; Berková A; Izáková S; Malinová E; Fuchs O; Kostecka A; Provazníková D; Filkuková J; Maaloufová J; Starý J; Michalová K
    Cancer Genet Cytogenet; 2009 Dec; 195(2):150-6. PubMed ID: 19963115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Significance of Mixed-Lineage Leukemia (MLL) Gene Detected by Real-Time Fluorescence Quantitative PCR Assay in Acute Myeloid Leukemia.
    Huang S; Yang H; Li Y; Feng C; Gao L; Chen GF; Gao HH; Huang Z; Li YH; Yu L
    Med Sci Monit; 2016 Aug; 22():3009-17. PubMed ID: 27561414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of a novel childhood acute myeloid leukaemia cell line, KOPM-88, containing partial tandem duplication of the MLL gene and an in vivo model for childhood acute myeloid leukaemia using NOD/SCID mice.
    Hayashi M; Kondoh K; Nakata Y; Kinoshita A; Mori T; Takahashi T; Sakamoto MI; Yamada T
    Br J Haematol; 2007 May; 137(3):221-32. PubMed ID: 17408461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based RT-PCR methods for the detection of the 8 most common MLL aberrations in acute leukemias.
    Burmeister T; Meyer C; Gröger D; Hofmann J; Marschalek R
    Leuk Res; 2015 Feb; 39(2):242-7. PubMed ID: 25510485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The initial level of MLL-partial tandem duplication affects the clinical outcomes in patients with acute myeloid leukemia.
    Kong J; Zhao XS; Qin YZ; Zhu HH; Jia JS; Jiang Q; Wang J; Zhao T; Huang XJ; Jiang H
    Leuk Lymphoma; 2018 Apr; 59(4):967-972. PubMed ID: 28745571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low frequency of MLL-partial tandem duplications in paediatric acute myeloid leukaemia using MLPA as a novel DNA screenings technique.
    Balgobind BV; Hollink IH; Reinhardt D; van Wering ER; de Graaf SS; Baruchel A; Stary J; Beverloo HB; de Greef GE; Pieters R; Zwaan CM; van den Heuvel-Eibrink MM
    Eur J Cancer; 2010 Jul; 46(10):1892-9. PubMed ID: 20233657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MLL-rearranged acute myeloid leukemia: Influence of the genetic partner in allo-HSCT response and prognostic factor of MLL 3' region mRNA expression.
    Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Carrillo E; Sánchez J; Pérez-López O; Pérez de Soto I; González Campos J; Prats-Martín C; Bernal R; Vargas MT
    Eur J Haematol; 2018 May; 100(5):436-443. PubMed ID: 29384595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia.
    Steudel C; Wermke M; Schaich M; Schäkel U; Illmer T; Ehninger G; Thiede C
    Genes Chromosomes Cancer; 2003 Jul; 37(3):237-51. PubMed ID: 12759922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ordering of mutations in acute myeloid leukemia with partial tandem duplication of MLL (MLL-PTD).
    Sun QY; Ding LW; Tan KT; Chien W; Mayakonda A; Lin DC; Loh XY; Xiao JF; Meggendorfer M; Alpermann T; Garg M; Lim SL; Madan V; Hattori N; Nagata Y; Miyano S; Yeoh AE; Hou HA; Jiang YY; Takao S; Liu LZ; Tan SZ; Lill M; Hayashi M; Kinoshita A; Kantarjian HM; Kornblau SM; Ogawa S; Haferlach T; Yang H; Koeffler HP
    Leukemia; 2017 Jan; 31(1):1-10. PubMed ID: 27389053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifelong persistence of AML associated MLL partial tandem duplications (MLL-PTD) in healthy adults.
    Bäsecke J; Podleschny M; Clemens R; Schnittger S; Viereck V; Trümper L; Griesinger F
    Leuk Res; 2006 Sep; 30(9):1091-6. PubMed ID: 16540167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cell-cell interacting genes distinguishes HLXB9/TEL from MLL-positive childhood acute myeloid leukemia.
    Wildenhain S; Ruckert C; Röttgers S; Harbott J; Ludwig WD; Schuster FR; Beldjord K; Binder V; Slany R; Hauer J; Borkhardt A
    Leukemia; 2010 Sep; 24(9):1657-60. PubMed ID: 20596032
    [No Abstract]   [Full Text] [Related]  

  • 18. Hyperdiploidy and duplication of der(11)ins(10;11)(p12;q23q14) in acute myeloid leukemia with MLL/MLLT10 fusion gene.
    Yamamoto K; Yakushijin K; Okamura A; Ueda S; Nakamachi Y; Kawano S; Matsuoka H; Minami H
    Leuk Lymphoma; 2013 Sep; 54(9):2055-8. PubMed ID: 23278644
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of a biochip-based assay integrated in a global strategy for identification of fusion transcripts in acute myeloid leukemia: a work flow for acute myeloid leukemia diagnosis.
    Giusiano S; Formisano-Tréziny C; Benziane A; Maroc N; Picard C; Hermitte F; Taranger-Charpin C; Gabert J
    Int J Lab Hematol; 2010 Aug; 32(4):398-409. PubMed ID: 19930410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myeloid leukemia with MLL rearrangements: clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cells.
    Muñoz L; Nomdedéu JF; Villamor N; Guardia R; Colomer D; Ribera JM; Torres JP; Berlanga JJ; Fernández C; Llorente A; Queipo de Llano MP; Sánchez JM; Brunet S; Sierra J;
    Leukemia; 2003 Jan; 17(1):76-82. PubMed ID: 12529663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.